打破障碍:骨髓微环境在多发性髓瘤进展中的作用
Aleksandra Agafonova1, Chiara Prinzi1, Angela Trovato Salinaro2
1Department of Biomedical and Biotechnological Sciences, Section of Medical Biochemistry, University of Catania, 95123 Catania, Italy.
International journal of molecular sciences
|August 14, 2025
概括
多发性髓瘤 (MM) 是一种骨髓癌. 骨髓屏障 (BMB) 支持癌细胞存活,这表明向MM细胞和BMB相互作用可能是一个新的治疗方法.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
背景情况:
- 多发性骨髓瘤 (MM) 是异常血细胞的一种不可治愈的癌症.
- 这些细胞在骨髓中繁殖,可以扩散到其他部位.
- 骨髓屏障 (BMB) 对MM细胞定位和疾病进展至关重要.
研究的目的:
- 审查骨髓屏障 (BMB) 的组成部分.
- 检查涉及多发性骨髓瘤 (MM) 病变发生的途径.
- 探索针对MM细胞和BMB相互作用的新疗法.
主要方法:
- 关于MM病变的文献综述.
- 分析BMB组件及其在MM中的作用.
- 检查MM细胞和BMB细胞之间的分子相互作用.
主要成果:
- 骨髓内皮细胞包括骨髓内皮细胞 (BMEC) 和骨髓 stromal 细胞 (BMSC).
- BMECs和BMSCs与MM细胞相互作用,分泌促进MM细胞存活和增殖的因素.
- 关键的途径包括粘附分子,血管性细胞因子,抗亡因子和生长信号.
结论:
- BMB微环境显著支持MM的进展.
- 了解MM细胞-BMB相互作用是MM病变的关键.
- 针对这些相互作用,为MM提供了一个有希望的治疗策略.
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Bone Marrow Sampling and Transplants
495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K


